Reneural Technologies Limited raised £475,000 in a funding round led by SFC Capital to advance its neurorehabilitation platform for stroke survivors.

Nov 06, 2024•9 months ago

Amount Raised

£475,000

Round Type

seed

LondonBiotechnologyHealth Care

Investors

Sfc Capital

Description

Reneural Technologies Limited has secured £475,000 to enhance its neurorehabilitation platform for stroke survivors. The funding will be used to grow its VR therapy offerings and expand into mental health support.

Company Information

Company

Reneural Technologies Limited

Location

London, England, United Kingdom

About

Reneural Technologies Limited, formerly known as CardioCrown, specializes in advancing neurorehabilitation platforms for stroke survivors. The company focuses on enhancing patient outcomes while reducing clinician burnout and healthcare costs through innovative technologies. Their solutions facilitate early hospital discharge and improve patient engagement and compliance. Reneural aims to become a leader in neurorehabilitation, expanding its offerings into VR therapy and mental health support.

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Reneural Technologies Limited raised £475,000 in a funding round led by SFC Capital to advance its neurorehabilitation platform for stroke survivors.

Investors

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information